|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 36/185 | |
| A61K 31/352 | |||
| A61K 31/35 | |||
| A61K 31/05 | |||
| A61K 45/06 | |||
| A61P 25/18 | |||
| A61P 25/22 |
| (11) | Number of the document | 2249848 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08869534.1 |
| Date of filing the European patent application | 2008-12-17 | |
| (97) | Date of publication of the European application | 2010-11-17 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2008/004217 |
| Date | 2008-12-17 |
| (87) | Number | WO 2009/087351 |
| Date | 2009-07-16 |
| (30) | Number | Date | Country code |
| 0800390 | 2008-01-04 | GB |
| (72) |
KIKUCHI, Tetsuro, JP
MAEDA, Kenji, JP
GUY, Geoffrey, GB
ROBSON, Philip, GB
STOTT, Colin, GB
|
| (73) |
GW Pharma Limited,
Sovereign House, Histon Cambridge CB24 9BZ,
GB
Otsuka Pharmaceutical Co., Limited, 9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535, JP |
| (54) | USE OF CANNABINOIDS IN COMBINATION WITH ARIPIPRAZOLE |
| USE OF CANNABINOIDS IN COMBINATION WITH ARIPIPRAZOLE |